Naphthalene has been shown to be a weak
carcinogen in rats. To investigate its mechanism of metabolic activation and
cancer initiation, mice were topically treated with
naphthalene or one of its metabolites,
1-naphthol, 1,2-dihydrodiolnaphthalene (1,2-DDN),
1,2-dihydroxynaphthalene (1,2-DHN), and
1,2-naphthoquinone (1,2-NQ). After 4 h, the mice were sacrificed, the treated skin was excised, and the depurinating and stable
DNA adducts were analyzed. The depurinating adducts were identified and quantified by ultraperformance liquid chromatography/tandem mass spectrometry, whereas the stable adducts were quantified by (32)P-postlabeling. For comparison, the stable adducts formed when a mixture of the four deoxyribonucleoside monophosphates was treated with 1,2-NQ or
enzyme-activated
naphthalene were also analyzed. The depurinating adducts 1,2-DHN-1-N3Ade and 1,2-DHN-1-N7Gua arise from reaction of 1,2-NQ with
DNA. Similarly, the major stable adducts appear to derive from the 1,2-NQ. The depurinating
DNA adducts are, in general, the most abundant. Therefore,
naphthalene undergoes metabolic activation to the electrophilic ortho-
quinone, 1,2-NQ, which reacts with
DNA to form depurinating adducts. This is the same mechanism as other weak
carcinogens, such as the natural and
synthetic estrogens, and
benzene.